Cat.#: ACPP-1583
| Despition | NRTN Human Recombinant |
| SIZE | 5 µg |
| Purity | > 96.0% (SDS-PAGE) |
| Form | Sterile Filtered White lyophilized (freeze-dried) powder. |
| Storage | Lyophilized was stored and desiccated below -18°C. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1020 | Recombinant Human Neurotensin Protein (Fc Tag) (AC1020) | 50 µg | inquiry |
| ACPP-1408 | Human SH3GL3 Protein (AC1408) | 5 µg | inquiry |
| ACPP-1024 | Recombinant Human FGF2 Protein (mutated Q65I + C96S + N111G). (AC1024) | 50 µg | inquiry |
| ACPP-1133 | Synthetic Nanodisc Human OR52D1 Protein (AC1133) | 10 µg | inquiry |
| ACPP-1597 | Human CRYGS Protein (AC1597) | 5 µg | inquiry |
| ACPP-1553 | Human NRG4 Protein (AC1553) | 2 µg | inquiry |
| ACPP-1739 | Human SYT3 Protein (AC1739) | 5 µg | inquiry |
| ACPP-1435 | Human CHGA Protein, His (AC1435) | 2 µg | inquiry |
| ACPP-1613 | Human RAB3IL1 Protein (AC1613) | 2 µg | inquiry |
| ACPP-1216 | PARD3 Blocking Peptide (AC1216) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.